Consensus reference gene (s) for gene expression studies in human cancers: end of the tunnel visible?

RN Sharan, ST Vaiphei, S Nongrum, J Keppen… - Cellular Oncology, 2015 - Springer
Background Gene expression studies are increasingly used to provide valuable information
on the diagnosis and prognosis of human cancers. Also, for in vitro and in vivo experimental …

Potential role of MALT1 as a candidate biomarker of disease surveillance and treatment response prediction in inflammatory bowel disease patients

Z Wu, Y Bi - Journal of Clinical Laboratory Analysis, 2022 - Wiley Online Library
Background Mucosa‐associated lymphoid tissue lymphoma translocation protein 1 (MALT1)
regulates adaptive and innate immune responses in several inflammatory disease …

MALT1 in asthma children: A potential biomarker for monitoring exacerbation risk and Th1/Th2 imbalance‐mediated inflammation

L Liu, Y Gao, Y Si, B Liu, X Liu, G Li… - Journal of Clinical …, 2022 - Wiley Online Library
Background Mucosa‐associated lymphoid tissue lymphoma translocation protein 1 (MALT1)
participates in the immune‐related allergic response and inflammation flare, while its clinical …

[HTML][HTML] Associations of A20, CYLD, cezanne and JAK2 genes and immunophenotype with psoriasis susceptibility

NH Giang, NTK Lien, DT Trang, PT Huong, NH Hoang… - Medicina, 2023 - mdpi.com
Background and Objectives: Psoriasis is an immune-mediated chronic inflammatory skin
disorder and commonly associated with highly noticeable erythematous, thickened and …

Blood MALT1, Th1, and Th17 cells are dysregulated, inter‐correlated, and correlated with disease activity in rheumatoid arthritis patients; meanwhile, MALT1 decline …

Z Ye, L Chen, Y Fang, L Zhao - Journal of Clinical Laboratory …, 2022 - Wiley Online Library
Objective Mucosa‐associated lymphoid tissue lymphoma translocation protein 1 (MALT1)
participates in inflammatory and autoimmune diseases via activating various signaling …

[HTML][HTML] The deubiquitinase inhibitor PR-619 sensitizes normal human fibroblasts to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cell …

RN Crowder, DT Dicker, WS El-Deiry - Journal of Biological Chemistry, 2016 - ASBMB
TNF-related apoptosis-inducing ligand (TRAIL) is a potential cancer therapy that selectively
targets cancer cell death while non-malignant cells remain viable. Using a panel of normal …

Effects of Vinblastine and Vincristine on the function of chronic myeloid leukemic cells through expression of A20 and CYLD

NH Hoang, NT Huyen, NX Canh… - Cellular and Molecular …, 2022 - cellmolbiol.org
Chronic myelogenous leukemia (CML) is characterised by the translocation of regions of the
BCR and ABL genes, leading to the fusion gene BCR-ABL forming the Philadelphia (Ph) …

[HTML][HTML] Исследование полиморфизмов генов-кандидатов иммунного ответа как маркеров риска развития ревматоидного артрита и продукции аутоантител

ИА Гусева, НВ Демидова, НЕ Сорока… - Научно …, 2016 - cyberleninka.ru
Цель исследования изучить распределение генотипов и аллелей генов PTPN22,
TNFA1P3, CTLA4, TNFA, IL6, 1L6R, 1L10, MCP1, 1CAM1 у больных ревматоидным …

[HTML][HTML] Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia

Y Ma, Z Liao, Y Xu, Z Zhong, X Wang, F Zhang… - European journal of …, 2014 - Springer
Background Knowledge of the oncogenic signaling pathways of T-cell acute lymphoblastic
leukemia (T-ALL) remains limited. Constitutive aberrant activation of the nuclear factor …

[HTML][HTML] Overexpression of MALT1-A20-NF-κB in adult B-cell acute lymphoblastic leukemia

Y Xu, J Hu, X Wang, L Xuan, J Lai, L Xu, S Chen… - Cancer cell …, 2015 - Springer
Background A20 is a dual inhibitor of NF-κB activation and apoptosis in the tumor necrosis
factor receptor 1 signaling pathway, and both are related to tumorigenesis. A20 is frequently …